Abdominal aortic aneurysm screening equipment evaluation report 2025
Updated 18 November 2026
Summary
This report outlines the evaluation exercise undertaken to select the next generation of ultrasound scanners to be used in the NHS Abdominal Aortic Aneurysm (AAA) Screening Programme in England.
We invited equipment suppliers to price against a comprehensive set of specification criteria developed by a Task and Finish Group (T&F) comprising a multi-disciplinary team of experts in ultrasound, national screening and equipment procurement. The team included staff working for local screening providers.
At the end of the evaluation period, 3 machines were identified as being best matched to the requirements of the AAA Screening Programme. These were the MIS Samsung HM70 Evo, Mindray M9 and Esaote MyLab Omega.
Background
The previous equipment evaluation in 2019 anticipated a 5-6 year lifespan for portable ultrasound systems in the NHS AAA Screening Programme. The 2025 evaluation followed a similar process, utilising videoconferencing to reduce travel time and costs, and speeding up the exercise. The timeline is shown in Table 1.
Equipment
The selection of imaging equipment for use in a population screening programme must satisfy a number of criteria. These include:
- performance and sensitivity
- portability of equipment from site to site
- weight and protection provided by system carry cases or trolleys
- availability of a stand for the scanner
- ease of use for screening technicians and clinical skills trainers including controls and ergonomics
- safety of the system and conformity to UK and European industry standards
- reliability to withstand packing and unpacking between clinics
- one touch image storage
- connectivity to the national programme IT system
- cost
- easy access to servicing and repair
Project stages
Task & Finish (T&F) Group
The T&F Group incorporated a wide range of experts including screening technicians, clinical skills trainers, physicist, NHS Supply Chain staff and core members from NHS England’s AAA Screening Programme, including quality assurance. It was essential to involve screening technicians and clinical skills trainers as they use the equipment daily. All confirmed they had no conflict of interest or commercial or financial involvement with ultrasound manufactures.
Development of the 2025 specification
The equipment specification document developed by the NHS AAA Screening Programme in 2019 was used as a starting point to develop the new specification for manufactures to submit tenders. This was amended to:
- include advances in portable ultrasound technology, including wireless capabilities
- reflect the working practices of local AAA screening services
- include specific details for carry cases, trolleys and equipment stands
Issue specification to suppliers
The T&F group developed a system for scoring the supplier responses against the specification criteria. This included ‘essential’ and ‘desirable’ criteria to help differentiate between equipment if a high number of submissions were received. The aim was to ensure the systems going forward met the criterion and could be further assessed at the evaluation day. Suppliers were also asked to submit only one scanning system that best met the specification rather than multiple.
The evaluation scoring system used the following scale: 2 ‘fully meets the criterion’, 1 ‘partially meets’ and 0 ‘does not meet’.
The NHS Supply Chain issued the specification to ultrasound suppliers on the NHS Supply Chain framework with a 2-week deadline for response.
Evaluation scoring method
A 3-stage evaluation process was agreed once the response to the specification had been received from the suppliers:-
- The first stage was paper-based, scoring the manufacturers’ written responses against ‘essential’ and ‘desirable’ specification criteria. Any machines that did not meet all of the ‘essential’ criteria would not be evaluated further.
- Following the paper-based evaluation, qualifying manufacturers were invited to bring their machines along to an evaluation day where they were again scored by the working group using both ‘essential’ and ‘desirable’ criteria and applying the 2,1,0 scores as described above.
- The 3 top scoring suppliers conducted field testing with local services to test the equipment in a clinical environment. The field tests were centred around 5 main categories: image quality, ease of use, physical features, workflow management, portability and ease of cleaning. To allow for greater discrimination, we used a 0 to 9 scoring range and a weighting was attached to the priority elements of the testing. The field tests were carried out by experienced technicians with support from supplier application specialists using the equipment in clinics with invited members of the public, some of whom were already on surveillance within the screening programme.
NHS Supply Chain and initial evaluation of written submissions
A total of 8 suppliers submitted tenders for the first stage paper-based evaluation. The group scored the responses to identify equipment that met the specification best while also considering the overall cost of procurement and maintenance. An overall score for each supplier was calculated from individual scores provided by each clinical member of the working group. Although there was some variability in the scores, there was not a significant difference to exclude any of the suppliers from progressing to the evaluation day. This may reflect advancements in imaging technology and that AAA screening requires only B-mode (brightness mode) imaging rather than Doppler ultrasound or other imaging modalities.
NHS Supply Chain invited the 8 suppliers to bring their ultrasound scanners, trolleys and transport cases, to a practical evaluation day to allow for thorough testing and evaluation of the equipment, including its portability between scanning venues.
Practical evaluation day
The practical evaluation day was undertaken at a venue in the East Midlands with workstations set up for each supplier for the morning and afternoon sessions. We divided the evaluation process into 5 main workgroups with the appropriate experts assigned to each team.
- Two clinical evaluation teams evaluated the imaging and clinical performance of each system, including the system display, transducer, usability and safety using a volunteer. The portability of equipment, including stands, cases and trollies was also assessed.
- A specification and clinical evaluation team evaluated technical aspects of scanner performance, portability and ergonomics including entry of patient data annotation. This included using a volunteer from the local screening service. Some of the clinical and specification evaluation criteria overlapped with the clinical evaluation teams to enable a comprehensive view of the clinical performance of each system and to allow for differentiation in the final scoring.
- Medical physics assessed the performance and physical features of the machines, including the use a tissue-mimicking ultrasound phantom to measure axial and lateral resolution and penetration of each system. Safety and infection control was evaluated
IT evaluation looked at connectivity, image storage and transfer via networks, including the capability of batch sending patient images from screening episodes over DICOM to the national programme IT system. This group included Digital Services Owner (AAA, Antenatal & Newborn Screening Programmes, Transformation Directorate, NHS England) and NEC Software Solutions AAA IT software experts. The connectivity and IT compatibility of the machines were tested using a pass or fail result.
The local AAA screening service (Leicester) invited men under surveillance to act as volunteer test subjects for the clinical and specification teams. The volunteers all provided consent and could also leave at any point during the evaluation day.
We developed a timetable for the evaluation day with clearly defined time slots (40 minutes) for each system to be evaluated. Thirteen experts from different disciplines assessed the 8 machines over the course of the day using an agreed scoring evaluation sheet. These were collated to produce an overall score.
Following collation of the scoring evaluation sheet results the working group agreed to reduce the number of machines from8 to 3. The suppliers that were not selected were provided with objective feedback collated from the working group by NHS Supply Chain detailing where the equipment had not met the criteria compared to the 3 successful suppliers.
Field testing
A further evaluation phase allowed screening technicians, clinical skills trainers and others to use the equipment in screening and surveillance clinics. This also enabled the IT connectivity of the systems to be fully tested in a clinical setting. Following consultation between local AAA services and NHS England, we agreed to hold field testing at 3 sites, 2 in the East Midlands and 1 in the North East.
We asked each supplier to attend each local service in turn during February 2025. The suppliers were provided with a detailed instruction sheet sent by NHS Supply Chain outlining the field-testing process including essential equipment and supplies to bring to each site. The supplier application specialists set the machines up and trained the technicians so field testing could be carried out.
The equipment was then used for a minimum of 2 full days of scanning with screening and surveillance patients.
The working group developed a field test scoring sheet and included an element of weighting to make sure the highest priority elements of the requirements were considered.
Results
We collated and distributed scoring results and feedback from the field test services to all working group members and field test programme managers.
The results were discussed in detail and a consensus reached based on considerations of the combined results of the supplier evaluation day and the field tests.
All 3 machines that underwent field-testing, MIS Samsung HM70 Evo, Mindray M9 and Esaote MyLab Omega were chosen as the approved ultrasound machines for AAA screening providers in England for at least next 5 years.
Providers can now progress with plans to procure ultrasound equipment from one of these 3 suppliers.
Trusts can contact NHS Supply Chain to purchase either system by emailing endoscopy.ultrasound@supplychain.nhs.uk.
Providers should be aware that the standard maintenance agreements provided by the suppliers for this exercise should be considered and discussed on an individual basis with the suppliers to make sure they meet local programme requirements.
A further evaluation exercise will be required to report no sooner than 2030-2031.
Feedback and lessons learnt
Feedback from the evaluation process was requested from suppliers by NHS Supply Chain and this will be incorporated in future evaluation exercises.
There were positive comments related to communication between the working group, NHS Supply Chain and the suppliers throughout the process.
Testing of IT connectivity was more difficult outside a hospital setting but essential IT functions could be tested on the day. This will need to be taken into consideration for future equipment evaluation projects and the venue selected.
Composition of the T&F Group
Lisa Summers (Quality & Improvement Lead - AAA/DES Screening Programmes, NHS England)
Rob Davis (Senior QA Advisor, Screening Quality Assurance Service, AAA/DES Screening Programmes, NHS England)
Rebecca Gledhill (Category Lead – Endoscopy & Ultrasound Diagnostics, Equipment and Services NHS Supply Chain)
Tim Hartshorne (Screening Professional Clinical Advisor - Ultrasound Imaging)
Justyna Janus (Non-Ionising Radiation Specialist Medical Physics Department University Hospitals of Leicester NHS Trust)
Steve Kawandami (Digital Services Owner, AAA, Antenatal & Newborn Screening Programmes, Transformation Directorate, NHS England)
Paris Lowcock (Category Manager – Ultrasound NHS Supply Chain)
Jennifer Matthews (Screening Team Leader, Derbyshire AAA Screening Service)
Kate Nicol (Programme Lead/Clinical Skills Tutor, North East and North Cumbria AAA Screening Service)
Annette Olalobo (Programme Manager, Leicester Screening Service)
Moyin Pelumi (Business Analyst – AAA Screening Health & DMS – Healthcare, NEC Software Solutions)
Lynda Pike (Programme Manager, Torbay and South Devon AAA Screening Service)
Carole Tennison (CST/QA Lead, North Yorkshire & Humber AAA Screening Service)
Julie Till-Wylie (Quality Assurance Advisor, Screening Quality Assurance Service, AAA/DES Screening Programmes, NHS England)
Alexandra Thompson (Screening Technician Team Leader, North East and North Cumbria AAA Screening Service)
Table 1. NHS AAA Equipment Evaluation T&F Group – timeline and process
| Task | Timeframe |
|---|---|
| Project commenced. Equipment specification together with scoring sheet reviewed by T&F Group and updated (Teams meeting) | Friday 25 October 2024 |
| One week response for further comments or revision via email | By Friday 1 November 2024 |
| T&F Group to discuss any further comments and finalise equipment specification (Teams meeting) | W/C 4 November 2024 |
| Specification sent to NHS Supply Chain | Friday 8 November 2024 |
| NHS Supply Chain to add to platform | Monday 11 November (3 weeks for suppliers to respond) |
| NHS Supply Chain to review responses from suppliers | W/C 2 December 2024 |
| Send suppliers submissions to T&F Group | W/C 9 December 2024 |
| T&F Group meeting set up to review responses from suppliers (Teams meeting) | W/C 16 December 2024 |
| Confirm to NHS Supply Chain suppliers to be invited to evaluation day | Friday 20 December 2024 |
| Practical evaluation day, 8 suppliers attending. T&F Group to attend evaluation event. Outcome, 3 suppliers were selected for further evaluation during field-testing in 3 AAA local screening services. The 5 unsuccessful suppliers were provided with feedback on the performance of their systems within 3 working days | Thursday 16 January 2025 |
| Field testing of 3 ultrasound systems to commence staggered over 3 weeks undertaken in 3 AAA local screening services | W/C Monday 3 February 2025 |
| T&F Group to meet to review the outcome and results of field-testing and agree recommended suppliers (Teams meeting) | Tuesday 18 March 2025 |
| Suppliers informed via NHS Supply Chain of outcome of the field-testing evaluation process.Suppliers informed via NHS Supply Chain of outcome of the field-testing evaluation process. | Monday 24 March |